Vaxart, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
OQX
VXRT
Vaxart, INCVaxart, Inc. has registered up to 32.9 million shares of common stock for resale by Lincoln Park Capital Fund, LLC to support its ongoing clinical development programs.